Stocks and Investing Stocks and Investing
Fri, January 26, 2018
Thu, January 25, 2018

Michael Schmidt Downgraded (BLUE) to Hold on, Jan 25th, 2018


Published on 2024-10-26 02:12:44 - WOPRAI, Michael Schmidt
  Print publication without navigation


Michael Schmidt of Leerink Swann, Downgraded "bluebird bio, Inc." (BLUE) to Hold on, Jan 25th, 2018.

Michael has made no other calls on BLUE in the last 4 months.



There are 9 other peers that have a rating on BLUE. Out of the 9 peers that are also analyzing BLUE, 4 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mark Breidenbach of "Oppenheimer" Initiated at Hold on, Thursday, December 21st, 2017
  • Jason McCarthy of "Maxim Group" Downgraded from Strong Buy to Hold on, Wednesday, December 13th, 2017
  • Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, November 6th, 2017
  • Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, November 3rd, 2017


These are the ratings of the 5 analyists that currently disagree with Michael


  • Biren Amin of "Jefferies" Upgraded from Hold to Strong Buy on, Monday, December 11th, 2017
  • John Newman of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $202 on, Tuesday, December 5th, 2017
  • Dane Leone of "BTIG" Upgraded from Hold to Strong Buy on, Thursday, November 2nd, 2017
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $162 on, Thursday, November 2nd, 2017
  • Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $162 on, Monday, October 30th, 2017
Contributing Sources